Cargando…

Sarcopenia as a risk factor of progression-free survival in patients with metastases: a systematic review and meta-analysis

BACKGROUND: Metastasis of cancer causes more than 90% of cancer deaths and is severely damaging to human health. In recent years, several studies have linked sarcopenia to shorter survival in patients with metastatic cancer. Several predictive models exist to predict mortality in patients with metas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luo, Lingli, Shen, Xiangru, Fang, Shuai, Wan, Teng, Liu, Pan, Li, Peiling, Tan, Haifeng, Fu, Yong, Guo, Weiming, Tang, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9906917/ https://www.ncbi.nlm.nih.gov/pubmed/36750774 http://dx.doi.org/10.1186/s12885-023-10582-2

Ejemplares similares

Locoregional progression-free survival of bone metastases from differentiated thyroid cancer
por: Luo, Jiaxin, et al.
Publicado: (2022)

The usefulness of progression-free survival in surgical treatment of lung metastases
por: Religioni, Jarosław, et al.
Publicado: (2022)

LncRNA, an Emerging Approach for Neurological Diseases Treatment by Regulating Microglia Polarization
por: Gao, Xiaoyu, et al.
Publicado: (2022)

Association of CT-Based Delta Radiomics Biomarker With Progression-Free Survival in Patients With Colorectal Liver Metastases Undergo Chemotherapy
por: Ye, Shuai, et al.
Publicado: (2022)

Sarcopenia for outcomes in patients undergoing spinal surgery: A protocol for a systematic review and pooled analysis of observational studies
por: Wan, Teng, et al.
Publicado: (2022)

Corrigendum: Association of CT-based delta radiomics biomarker with progression-free survival in patients with colorectal liver metastases undergo chemotherapy
por: Ye, Shuai, et al.
Publicado: (2023)

Prognostic significance of sarcopenia diagnosed based on the anthropometric equation for progression-free survival and overall survival in patients with colorectal cancer
por: Xie, Hailun, et al.
Publicado: (2023)

Sarcopenia in Patients With Spinal Metastasis: A Systematic Review and Meta-Analysis of Retrospective Cohort Studies
por: Tan, Haifeng, et al.
Publicado: (2022)

Sarcopenia is associated with worse surgical complications but not relapse-free survival and overall survival in patients with retroperitoneal liposarcoma
por: Zhao, Mingkun, et al.
Publicado: (2022)

Temporalis muscle thickness as an indicator of sarcopenia predicts progression-free survival in head and neck squamous cell carcinoma
por: Lee, Boeun, et al.
Publicado: (2021)

Microglia Pyroptosis: A Candidate Target for Neurological Diseases Treatment
por: Wu, Xian, et al.
Publicado: (2022)

Sarcopenia does not limit overall survival after interstitial brachytherapy for breast cancer liver metastases
por: Thormann, Maximilian, et al.
Publicado: (2022)

The Clinical Impact of Combining Neutrophil-to-Lymphocyte Ratio with Sarcopenia for Improved Discrimination of Progression-Free Survival in Patients with Colorectal Cancer
por: Lee, Su Young, et al.
Publicado: (2022)

NLRP3-Dependent Pyroptosis: A Candidate Therapeutic Target for Depression
por: Wan, Teng, et al.
Publicado: (2022)

Research Progress on Mechanism of Neuroprotective Roles of Apelin-13 in Prevention and Treatment of Alzheimer’s Disease
por: Wan, Teng, et al.
Publicado: (2021)

Analysis of Prognostic Factors Affecting the Brain Metastases Free Survival and Survival After Brain Metastases in Breast Cancer
por: Xiao, Weikai, et al.
Publicado: (2020)

Primary tumor location affects recurrence-free survival for patients with colorectal liver metastases after hepatectomy: a propensity score matching analysis
por: Zhang, Yuanping, et al.
Publicado: (2020)

Percutaneous radiofrequency ablation of solitary hepatic metastases from colorectal cancer: risk factors of local tumor progression-free survival and overall survival
por: Lee, Hyun Jae, et al.
Publicado: (2022)

MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2022)

Brain metastases free survival differs between breast cancer subtypes
por: Berghoff, A, et al.
Publicado: (2012)

Anterior cruciate ligament deficiency versus intactness for outcomes in patients after unicompartmental knee arthroplasty: a systematic review and meta-analysis
por: Guo, Weiming, et al.
Publicado: (2022)

Survival time and prognostic factors of patients with initial noncurative colorectal liver metastases
por: Liu, Qizhi, et al.
Publicado: (2017)

Preoperative lymphocyte-to-monocyte ratio represents a superior predictor compared with neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios for colorectal liver-only metastases survival
por: Peng, Jianhong, et al.
Publicado: (2017)

Corrigendum: MRI radiomics predicts progression-free survival in prostate cancer
por: Jia, Yushan, et al.
Publicado: (2023)

Prognostic value of sarcopenia in patients with colorectal liver metastases undergoing hepatic resection
por: Liu, Yueh-Wei, et al.
Publicado: (2020)

Pathologic-Based Nomograms for Predicting Overall Survival and Disease-Free Survival Among Patients with Locally Advanced Rectal Cancer
por: Liu, Shuai, et al.
Publicado: (2021)

Similarity and diversity of the tumor microenvironment in multiple metastases: critical implications for overall and progression-free survival of high-grade serous ovarian cancer
por: Heindl, Andreas, et al.
Publicado: (2016)

Trastuzumab Deruxtecan Improves Progression-Free Survival and Intracranial Response in Patients with HER2-Positive Metastatic Breast Cancer and Brain Metastases
por: Jacobson, Anne
Publicado: (2022)

Sarcopenia supersedes subjective global assessment as a predictor of survival in colorectal cancer
por: Vashi, Pankaj G., et al.
Publicado: (2019)

Prognostic Significance of Preoperative Sarcopenia in Patients With Gastric Cancer Liver Metastases Receiving Hepatectomy
por: Xiong, Jianping, et al.
Publicado: (2022)

Value of sarcopenia in the resection of colorectal liver metastases—a systematic review and meta-analysis
por: Wagner, D., et al.
Publicado: (2023)

Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
por: Belin, Lisa, et al.
Publicado: (2020)

The effect of sarcopenia and sarcopenic obesity on survival in gastric cancer
por: Şahin, Muzaffer Ece Hakan, et al.
Publicado: (2023)

Response to first‐line treatment predicts progression‐free survival benefit of small‐cell lung cancer patients treated with anlotinib
por: Qin, Boyu, et al.
Publicado: (2021)

Vimentin expression in circulating tumor cells (CTCs) associated with liver metastases predicts poor progression-free survival in patients with advanced lung cancer
por: Wang, Ying, et al.
Publicado: (2019)

MRI radiomic signature predicts intracranial progression-free survival in patients with brain metastases of ALK-positive non-small cell lung cancer
por: Zhao, Shijun, et al.
Publicado: (2021)

Upfront brain radiotherapy improves intracranial progression-free survival but not overall survival in lung adenocarcinoma patients with brain metastases: a retrospective, single-institutional analysis from China
por: Jiang, Aijun, et al.
Publicado: (2022)

Association of Sarcopenia With Toxicity and Survival in Postoperative Recurrent Esophageal Squamous Cell Carcinoma Patients Receiving Chemoradiotherapy
por: Xu, Ying-Ying, et al.
Publicado: (2021)

The Effect of Resistance Training on the Rehabilitation of Elderly Patients with Sarcopenia: A Meta-Analysis
por: Zhao, Haotian, et al.
Publicado: (2022)

Sarcopenia Best Predicts Complications in Free Flap Breast Reconstruction
por: Jain, Nirbhay S., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_a5cb5ieefppdh0p0p3l88k29dn